Latest Breaking News On - Office of pharmacy - Page 2 : comparemela.com
Los presidentes de los Colegios Farmacéuticos eligen a la candidatura de Jesús Aguilar para liderar el Consejo General durante los próximos años
pmfarma.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmfarma.es Daily Mail and Mail on Sunday newspapers.
El burgalés Jesús Aguilar seguirá al frente de Consejo General de Colegios Oficiales de Farmacéuticos
elcorreodeburgos.elmundo.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elcorreodeburgos.elmundo.es Daily Mail and Mail on Sunday newspapers.
New York Governor Andrew Cuomo says the new Office of Pharmacy Benefits is investigating big price increases for six drugs connected to the COVID-19 pandemic.
The government is looking into price increases for treatments that went up by, on the low end, around 60% to over 1,350% for one drug during the pandemic.
Kathy Whyte/ WNBF News
The Department of Financial Services says a formulation of Vitamin C that goes into IVs manufactured by McGuff Pharmaceuticals went up in price 110% about a week after clinical trials were announced for using the drug as a treatment of COVID patients with severe symptoms.
A steroid treatment produced by Cipla USA, Incorporated had its price increased by over 1,350% in the middle of the first wave of COVID-19 cases in the U.S. and right after the announcement of clinical trials.
Fingerlakes1.com
Menu
Have a tip for the newsroom, press release, local event listing or digital content to share? Send it here. Support our mission by visiting patreon.com/fl1 and becoming a monthly subscriber.
New York State is launching an investigation into the rise of prescription drug prices during the COVID-19 pandemic.
Gov. Andrew Cuomo announced that the Department of Financial Services’ newly formed Office of Pharmacy Benefits has initiated investigations into significant price spikes for six drugs that were connected to the COVID-19 pandemic by sending a demand pursuant to New York Insurance Law Section 111 requiring a statement from the manufacturer explaining the facts and circumstances surrounding the spikes.
By Reuters Staff
2 Min Read
Jan 21 (Reuters) - New York Governor Andrew Cuomo said on Thursday the Department of Financial Services was investigating into a price jump of about 60% to 1,350% in six drugs during the COVID-19 pandemic.
New York has asked drug manufacturers to explain the large spike in prices of the drugs, which included dexamethasone, a treatment proven to decrease deaths in COVID-19 patients, and chloroquine phosphate, which was touted by former President Donald Trump as a cure, but turned out ineffective.
The price for Cipla USA Inc’s Budesonide soared by over 1,350% during the first wave of the pandemic in the United States and on the heels of an announcement of clinical trials for its use against COVID-19, according to a statement released by the governor.
vimarsana © 2020. All Rights Reserved.